 The organization grew out of an "informal coalition" of support groups and families called together in the late 1970s to advocate legislation supporting development of orphan drugs, or drugs for treating rare diseases.They succeeded in getting the United States Congress to pass the Orphan Drug Act (ODA) in early 1983.The initial coalition was led by Abbey Meyers, whose son had Tourette syndrome.